AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

MindWalk Holdings Corp.

$1.33 -$0.69 (-34.16%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$1.3
Day Range
$1.31$1.34
Year Range
$0.99$2.99
Market Cap
62.49M
AVG Volume
294.45K
Trailing/Forward PE
-6.06/-
PEG ratio
0.26
Dividend Yield
-
Next Earnings Date
2026-09-14
Primary Exchange
NASDAQUS
Revenue (CAD)
010M20M30M2017201820192020202120222023202420252026
HYFT Revenue (CAD) by year
PeriodRevenue (CAD)
202615.45M
202518.28M
202424.52M
202320.66M
202219.36M
202117.91M
202014.06M
201910.93M
20185.44M
20172.63M
Net Income (CAD)
-40M-30M-20M-10M02017201820192020202120222023202420252026
HYFT Net Income (CAD) by year
PeriodNet Income (CAD)
2026-13.85M
2025-30.23M
2024-26.55M
2023-26.56M
2022-16.71M
2021-7.34M
2020-4.95M
2019-7.62M
2018-5.17M
2017-5.38M
Operating Income (CAD)
-30M-20M-10M02017201820192020202120222023202420252026
HYFT Operating Income (CAD) by year
PeriodOperating Income (CAD)
2026-14.82M
2025-13.54M
2024-8.97M
2023-28.22M
2022-16.47M
2021-4.17M
2020-4.05M
2019-6.25M
2018-4.71M
2017-1.38M
EBITDA (CAD)
-40M-30M-20M-10M02017201820192020202120222023202420252026
HYFT EBITDA (CAD) by year
PeriodEBITDA (CAD)
2026-13.95M
2025-30.18M
2024-22.41M
2023-21.04M
2022-11.84M
2021-1.45M
2020-190.14K
2019-4.03M
2018-4.35M
2017-5.4M
Cash Flows (CAD)
-30M-20M-10M02017201820192020202120222023202420252026
HYFT Cash Flows (CAD) by year
PeriodCash Flows (CAD)
2026-12.92M
2025-7.21M
2024-14.99M
2023-21.33M
2022-11.18M
2021-2.03M
2020-1.97M
2019-3.85M
2018-3.76M
2017-934.56K
EPS (CAD)
-1.5-1-0.502017201820192020202120222023202420252026
HYFT EPS (CAD) by year
PeriodEPS (CAD)
2026-0.31
2025-0.99
2024-1
2023-1.07
2022-0.85
2021-0.44
2020-0.37
2019-0.6
2018-0.57
2017-1.32
Expenses (CAD)
010M20M30M40MR&DSG&ACapex2017201820192020202120222023202420252026
HYFT Expenses (CAD) by year
PeriodExpenses (CAD)
202624.33M
202522.89M
202424.19M
202337.19M
202226.29M
202116.66M
20209.05M
20199.09M
20186.12M
20173.19M
Cash & Debt (CAD)
020M40M60MCashLong Term DebtShort Term Debt2017201820192020202120222023202420252026
HYFT Cash & Debt (CAD) by year
PeriodCash & Debt (CAD)
202611.33M
202510.66M
20243.46M
20238.28M
202229.96M
202141.76M
20202.61M
20195.47M
20181.81M
20172.58M
Debt ratios
-202420192020202120222023202420252026
HYFT Debt ratios by year
PeriodDebt ratios
20260.09
2025-0.03
2024-0.2
20230.03
20221.55
20213.82
2020-0.14
20190.18
Margins
0%20%40%60%80%2017201820192020202120222023202420252026
HYFT Margins by year
PeriodMargins
202658.79%
202555.43%
202449.16%
202355.95%
202256.72%
202164.42%
202057.15%
201946.75%
201844.63%
201741.41%
Return on Capital
-200%-150%-100%-50%0%2017201820192020202120222023202420252026
HYFT Return on Capital by year
PeriodReturn on Capital
2026-118.09%
2025-127.97%
2024-78.27%
2023-45.95%
2022-22.19%
2021-12.92%
2020-32.8%
2019-42.16%
2018-40.71%
2017-174.12%
Shares Outstanding
020M40M60M2017201820192020202120222023202420252026
HYFT Shares Outstanding by year
PeriodShares Outstanding
202646.71M
202533.12M
202426.95M
202325.03M
202220.76M
202116.87M
202013.6M
201913.43M
20189.45M
20177.72M
Book Value Per Share (CAD)
012342017201820192020202120222023202420252026
HYFT Book Value Per Share (CAD) by year
PeriodBook Value Per Share (CAD)
20260.25
20250.71
20241.26
20232.31
20223.63
20213.37
20201.11
20191.35
20181.34
20170.4
Total Assets (CAD)
025M50M75M100M2017201820192020202120222023202420252026
HYFT Total Assets (CAD) by year
PeriodTotal Assets (CAD)
202621.34M
202544.44M
202459.99M
202377.83M
202293.44M
202166.96M
202027.26M
201928.35M
201824.58M
20173.93M
Employee Count
0255075100202420252026
HYFT Employee Count by year
PeriodEmployee Count
202674
202581
202472
Free Cash Flow Yield
-80%-60%-40%-20%0%med -14.89%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
HYFT Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-15.22%
Sep 26-15.15%
Aug 26-14.31%
Aug 26-14.25%
Aug 26-14.14%
Aug 26-15.15%
Jul 26-15.3%
Jul 26-14.43%
Jul 26-12.49%
Jul 26-12.64%
Jul 26-11.48%
Jun 26-11.41%
Jun 26-11.82%
Jun 26-11.72%
Jun 26-10.92%
May 26-10.54%
May 26-10.82%
May 26-15.63%
May 26-14.72%
May 26-15.55%
Apr 26-15.34%
Apr 26-14.04%
Apr 26-17.27%
Apr 26-16.12%
Mar 26-17.2%
Mar 26-16.07%
Mar 26-15.03%
Mar 26-14.76%
Feb 26-14.41%
Feb 26-12.4%
Feb 26-11.74%
Feb 26-10.35%
Jan 26-10.07%
Jan 26-7.14%
Jan 26-7.71%
Jan 26-5.87%
Jan 26-8.01%
Dec 25-9.56%
Dec 25-9.64%
Dec 25-9.96%
Dec 25-8.78%
Nov 25-8.43%
Nov 25-10.31%
Nov 25-10.3%
Nov 25-9.99%
Oct 25-9.27%
Oct 25-10.57%
Oct 25-10.96%
Oct 25-9.58%
Oct 25-10.3%
Sep 25-9.67%
Sep 25-10.18%
Sep 25-7.12%
Sep 25-8.12%
Aug 25-6.69%
Aug 25-4.92%
Aug 25-7.88%
Aug 25-7.91%
Aug 25-9.63%
Jul 25-9.75%
Jul 25-12.16%
Jul 25-14.25%
Jul 25-16.22%
Jun 25-19.01%
Jun 25-21.02%
Jun 25-30.3%
Jun 25-31.35%
May 25-36.86%
May 25-37.74%
May 25-41.76%
May 25-46.15%
May 25-45.51%
Apr 25-46.31%
Apr 25-47.64%
Apr 25-48.27%
Apr 25-56.37%
Mar 25-51.44%
Mar 25-50.73%
Mar 25-55.7%
Mar 25-54.75%
Feb 25-62.08%
Feb 25-56.13%
Feb 25-51.51%
Feb 25-43.49%
Jan 25-45.6%
Jan 25-37.27%
Jan 25-40.14%
Jan 25-40.43%
Jan 25-41.03%
Dec 24-52.14%
Dec 24-53.58%
Dec 24-53.69%
Dec 24-45.74%
Nov 24-46.25%
Nov 24-46.83%
Nov 24-39.3%
Nov 24-40.22%
Nov 24-42.26%
Oct 24-26.12%
Oct 24-33.02%
Price to Sales
0246810med 4.25Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
HYFT Price to Sales by year
PeriodPrice to Sales
Sep 265.49
Sep 265.52
Aug 265.84
Aug 265.87
Aug 265.91
Aug 265.52
Jul 265.46
Jul 265.79
Jul 265.19
Jul 265.13
Jul 265.64
Jun 265.68
Jun 265.48
Jun 265.53
Jun 265.93
May 266.15
May 265.99
May 264.14
May 264.4
May 264.17
Apr 264.22
Apr 264.61
Apr 263.75
Apr 264.02
Mar 263.77
Mar 264.03
Mar 264.31
Mar 263.4
Feb 263.48
Feb 264.05
Feb 264.28
Feb 264.85
Jan 264.99
Jan 267.03
Jan 266.51
Jan 268.55
Jan 266.27
Dec 255.25
Dec 255.21
Dec 255.09
Dec 255.77
Nov 256.01
Nov 254.92
Nov 254.92
Nov 255.08
Oct 255.47
Oct 254.79
Oct 254.63
Oct 255.29
Oct 254.92
Sep 255.24
Sep 254.98
Sep 255.54
Sep 254.86
Aug 255.9
Aug 258.01
Aug 255
Aug 254.98
Aug 254.1
Jul 255.47
Jul 254.39
Jul 253.75
Jul 253.29
Jun 252.81
Jun 252.54
Jun 251.76
Jun 251.7
May 251.45
May 251.41
May 251.28
May 251.16
May 251.17
Apr 251.15
Apr 251.12
Apr 251.11
Apr 250.95
Mar 251.04
Mar 250.96
Mar 250.87
Mar 250.89
Feb 250.78
Feb 250.87
Feb 250.94
Feb 251.12
Jan 251.07
Jan 251.3
Jan 251.21
Jan 251.2
Jan 251.18
Dec 240.93
Dec 240.91
Dec 240.91
Dec 240.69
Nov 240.68
Nov 240.67
Nov 240.8
Nov 240.78
Nov 240.74
Oct 241.2
Oct 240.95
EV/EBITDA
50100150200250med 122.78Oct 20Nov 20Jan 21Feb 21Apr 21Jun 21Jul 21
HYFT EV/EBITDA by year
PeriodEV/EBITDA
Jul 21103.8
Jul 2163.59
Jul 2163.7
Jul 2171.84
Jun 2174.72
Jun 2180.09
Jun 2182.56
Jun 2183.59
May 2190.46
May 2197.89
May 2192.05
May 2189.65
Apr 21116.86
Apr 21115.49
Apr 21123.58
Apr 21152.07
Apr 21127.75
Mar 21119.44
Mar 21124.2
Mar 21141.48
Mar 21146.08
Feb 21170.15
Feb 21202.73
Feb 21181.81
Feb 21191.81
Jan 21143.8
Jan 21132.34
Jan 21122.78
Jan 21138.05
Dec 20125.6
Dec 20245.81
Dec 20164.65
Dec 20139.36
Dec 20109.86
Nov 20115.75
Nov 2097.64
Nov 20105.23
Nov 20121.23
Oct 20120.86
Oct 20142.16
Oct 20135.88
Oct 20155.62
Oct 20162.1
Price/Operating Cashflow
100200300400500600med 280.38Jan 21Mar 21Apr 21May 21Jun 21Jul 21
HYFT Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Jul 21304.57
Jul 21194.44
Jul 21194.73
Jul 21217.03
Jun 21224.93
Jun 21239.63
Jun 21246.41
Jun 21249.22
May 21268.03
May 21288.37
May 21272.39
May 21265.82
Apr 21340.36
Apr 21336.58
Apr 21358.76
Apr 21436.79
Apr 21370.19
Mar 21347.41
Mar 21360.44
Mar 21407.79
Mar 21420.4
Feb 21486.32
Feb 21575.57
Feb 21518.24
Feb 21545.66
Jan 21267.61
Jan 21247.09
Jan 21229.94
Jan 21257.31
Dec 20235
Price to Book
02.557.51012.5med 4.44Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
HYFT Price to Book by year
PeriodPrice to Book
Sep 267.24
Sep 267.27
Aug 267.7
Aug 267.73
Aug 267.79
Aug 267.27
Jul 267.2
Jul 267.63
Jul 268.68
Jul 268.58
Jul 269.44
Jun 269.5
Jun 269.17
Jun 269.25
Jun 269.93
May 2610.29
May 2610.01
May 266.93
May 267.36
May 266.97
Apr 267.07
Apr 267.72
Apr 266.28
Apr 266.73
Mar 266.3
Mar 266.75
Mar 267.21
Mar 263.92
Feb 264.02
Feb 264.67
Feb 264.93
Feb 265.6
Jan 265.75
Jan 268.11
Jan 267.51
Jan 269.86
Jan 267.23
Dec 256.06
Dec 256.01
Dec 254.66
Dec 255.28
Nov 255.5
Nov 254.5
Nov 254.5
Nov 254.64
Oct 255
Oct 254.39
Oct 254.23
Oct 254.84
Oct 254.5
Sep 254.79
Sep 254.55
Sep 254.29
Sep 253.76
Aug 254.56
Aug 256.2
Aug 253.87
Aug 253.86
Aug 253.17
Jul 253.87
Jul 253.1
Jul 252.65
Jul 252.33
Jun 251.99
Jun 251.8
Jun 251.25
Jun 251.2
May 251.02
May 251
May 250.9
May 250.82
May 250.83
Apr 250.81
Apr 250.79
Apr 250.78
Apr 250.67
Mar 250.73
Mar 250.52
Mar 250.48
Mar 250.48
Feb 250.43
Feb 250.47
Feb 250.51
Feb 250.61
Jan 250.58
Jan 250.71
Jan 250.66
Jan 250.66
Jan 250.65
Dec 240.51
Dec 240.49
Dec 240.49
Dec 240.44
Nov 240.44
Nov 240.43
Nov 240.52
Nov 240.51
Nov 240.48
Oct 240.78
Oct 240.62
MindWalk Holdings Corp.
HYFT
Stockpicker

Video analysis: HYFT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: HYFT

AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033

gurufocus.com · 14 Sep 2026

AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033

AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033PR NewswireAUSTIN, Texas, Sept. 14, 2026AUSTIN, Texas, Sept. 14, 2026 /PRNewswire/ -- USA News

MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion

gurufocus.com · 14 Sep 2026

MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion

MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it has entered into a binding commitment with Sanabil (Cayman

MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion

businesswire.com · 14 Sep 2026

MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it has entered into a binding commitment with Sanabil (Cayman) for a senior unsecured revolving credit facility of up to US$30 million. The facility is intended to support MindWalk's biologics programs, commercial expansion, working capital, and general corporate purposes. The facility carries a fixed annual interest rate of 7.00%, accruing only on amounts drawn, an.

MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

businesswire.com · 10 Sep 2026

MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it is participating in the H.C. Wainwright 28th Annual Global Investment Conference, held September 14 - 16, 2026 at the Lotte New York Palace Hotel in New York, where a pre-recorded fireside chat with Chief Executive Officer Dr. Jennifer Bath is available to registered attendees on demand. “The question institutional investors are working through is where durable v.

MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026

businesswire.com · 8 Sep 2026

MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk” or the “Company”) (NASDAQ: HYFT), a Bio-Native AI company, today announced that it will report financial results for the first quarter of fiscal year 2027 and host a conference call on Monday, September 14, 2026, at 5:00 p.m. Eastern Time. Financial results will be issued in a press release prior to the call, which will include a management presentation followed by a question-and-answer session. Conference Call and Webcast Deta.

The Market Just Told You Which Layer Of AI Biology It Is Paying For

globenewswire.com · 3 Sep 2026

The Market Just Told You Which Layer Of AI Biology It Is Paying For

AUSTIN, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Market Updates News Commentary - Earnings season in life sciences technology has just delivered an unusually clean verdict. The company that owns the industry's data and systems of record beat and jumped. The company selling model-informed software into the same customers missed and fell by roughly the same amount on the day.

A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed

gurufocus.com · 24 Jul 2026

A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed

A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed

MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI

businesswire.com · 23 Jul 2026

MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today unveiled the first public demonstration of ReefIQ™, its biological context layer for AI drug discovery, running on AMD Instinct™ at AMD's Advancing AI 2026 in San Francisco. MindWalk is featured in the AMD Instinct™ Demo Showcase, appearing in one of four custom demo vignettes, with an accompanying video interview distributed through AMD's channels. The demonstration is the first.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.